Levocabastine
Back to searchMolecule Structure
Scientific Name
Levocabastine
Description of the Drug
Levocabastine is a selective histamine H1 receptor antagonist indicated for the management of seasonal allergic conjunctivitis symptoms.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01106
http://www.drugbank.ca/drugs/DB01106
Brand Name(s)
Livostin direct
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4577 | |
| DrugBank | DB01106 | |
| PubChem: Thomson Pharma | 15501039 | |
| LINCS | LSM-2731 | |
| Nikkaji | J358.848C | |
| BindingDB | 50019405 | |
| EPA CompTox Dashboard | DTXSID1048548 | |
| DrugCentral | 1564 | |
| Guide to Pharmacology | 1586 | |
| rxnorm | LEVOCABASTINE HYDROCHLORIDE | LEVOCABASTINE |
| ChEBI | 135679 | |
| ZINC | ZINC000100089496 |
